Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday
Top Cited Papers
- 31 January 2013
- journal article
- review article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 126 (1), 13-20
- https://doi.org/10.1016/j.amjmed.2012.06.023
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)Journal of Bone and Mineral Research, 2011
- Atypical fractures and bisphosphonate therapy: A cohort study of patients with femoral fracture with radiographic adjudication of fracture site and featuresBone, 2011
- Trends in Incidence of Subtrochanteric Fragility Fractures and Bisphosphonate Use Among the US Elderly, 1996–2007Journal of Bone and Mineral Research, 2010
- Exposure to Oral Bisphosphonates and Risk of Esophageal CancerJama-Journal Of The American Medical Association, 2010
- Effect of Osteoporosis Treatment on Mortality: A Meta-AnalysisJournal of Clinical Endocrinology & Metabolism, 2010
- Comparative gastrointestinal safety of weekly oral bisphosphonatesOsteoporosis International, 2009
- Incidence of stress fractures of the femoral shaft in women treated with bisphosphonateActa Orthopaedica, 2009
- Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holidayOsteoporosis International, 2008
- Safety Considerations with Bisphosphonates for the Treatment of OsteoporosisDrug Safety, 2007
- Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal OsteoporosisJournal of Bone and Mineral Research, 2004